Pentoxifylline Tablet, Extended Release
Product Images NDC 60505-0033

2 FDA label images from Apotex Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pentoxifylline (NDC 60505-0033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

400mg-100btl.jpg (400mg 100btl)

400mg-100btl.jpg (400mg 100btl)
Label for Pentoxifylline Extended-Release Tablets, USP, 400 mg oral dosage form. The label shows a count of 100 tablets with NDC 60505-0033-6, manufactured by Apotex Corp. Storage instructions and dispensing guidelines are included, with emphasis on storing at controlled room temperature in a light-resistant container.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient pentoxifylline, showing its molecular configuration with annotated atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.